News

GE HealthCare Stock May Gain as FDA Approves Optison for Pediatric Use
GEHC's Optison ultrasound agent receives FDA approval for pediatric use, improving echocardiogram clarity and advancing heart ...
MPR3d
FDA Approves Use of Optison in Pediatric Patients With Suboptimal Echocardiograms
The Food and Drug Administration (FDA) has approved Optison ™ (perflutren protein-type A microsphere) injectable suspension for use in pediatric patients with suboptimal echocardiograms to opacify the ...
Jim Cramer: SoFi Goes To 'New Highs,' Recommends Not Buying This Health Care Stock
The Wall Street veteran's technical analysis of natural gas helped members capture gains on UNG calls. His recent alert ...
MedPage Today4d
Low LDL and Bleeding Risk; Improved HoFH Life Expectancy; ANGPTL4 mAb Progress
Low LDL cholesterol was associated with an increased risk of bleeding in patients receiving anticoagulation for venous ...
GE HealthCare Announces FDA Approval of Pediatric Indication for Optison Ultrasound Enhancing Agent
GE HealthCare (Nasdaq: GEHC) today announced the U.S. Food and Drug Administration (FDA) has approved a pediatric indication ...
clinicalpainadvisor.com26d
Poor Communication Major Contributor to Patient Safety Incidents
Poor communication contributed to 24% of safety incidents in 42 studies that examined its contribution along with other causes. HealthDay News — Poor communication is a major contributor to ...
contemporarypediatrics27d
New blood test predicts preterm birth risk early in pregnancy
A cheap, non-invasive test using cell-free DNA (cfDNA) collected during standard early pregnancy testing may be used to predict preterm birth (PTB) risk, according to a recent study published in PLOS ...